FACULTAD DE MEDICINA
Facultad
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (35)
2024
-
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
Journal of Clinical Investigation, Vol. 134, Núm. 8
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Association of Early Pregnancy Perfluoroalkyl and Polyfluoroalkyl Substance Exposure With Birth Outcomes
JAMA Network Open, Vol. 6, Núm. 5
-
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Red Blood Cell Folate Modifies the Association between Serum Per- and Polyfluoroalkyl Substances and Antibody Concentrations in U.S. Adolescents
Environmental Science and Technology, Vol. 57, Núm. 6, pp. 2445-2456
-
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations
Nature genetics, Vol. 55, Núm. 3, pp. 369-376
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Is minimally invasive orthopedic surgery safer than open? A systematic review of systematic reviews
International Journal of Surgery, Vol. 101
2021
-
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z)
Nature Communications
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Nature Communications, Vol. 12, Núm. 1
2019
-
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
The Lancet Oncology, Vol. 20, Núm. 10, pp. e566-e581
-
A resistance-sensing mechanical injector for the precise delivery of liquids to target tissue
Nature Biomedical Engineering, Vol. 3, Núm. 8, pp. 621-631
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911
-
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
-
Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling
Cell Reports, Vol. 22, Núm. 5, pp. 1301-1312
-
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations
Genome Medicine, Vol. 10, Núm. 1